BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 16260900)

  • 1. Primary HIV-1 infection sets the stage for important B lymphocyte dysfunctions.
    Titanji K; Chiodi F; Bellocco R; Schepis D; Osorio L; Tassandin C; Tambussi G; Grutzmeier S; Lopalco L; De Milito A
    AIDS; 2005 Nov; 19(17):1947-55. PubMed ID: 16260900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of memory (CD27) B lymphocytes in HIV-1 infection.
    De Milito A; Mörch C; Sönnerborg A; Chiodi F
    AIDS; 2001 May; 15(8):957-64. PubMed ID: 11399977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunological benefits of antiretroviral therapy in very early stages of asymptomatic chronic HIV-1 infection.
    Plana M; García F; Gallart T; Tortajada C; Soriano A; Palou E; Maleno MJ; Barceló JJ; Vidal C; Cruceta A; Miró JM; Gatell JM
    AIDS; 2000 Sep; 14(13):1921-33. PubMed ID: 10997396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid restoration of CD4 T cell subsets in subjects receiving antiretroviral therapy during primary HIV-1 infection.
    Kaufmann GR; Zaunders JJ; Cunningham P; Kelleher AD; Grey P; Smith D; Carr A; Cooper DA
    AIDS; 2000 Dec; 14(17):2643-51. PubMed ID: 11125882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beneficial Effects of cART Initiated during Primary and Chronic HIV-1 Infection on Immunoglobulin-Expression of Memory B-Cell Subsets.
    Pogliaghi M; Ripa M; Pensieroso S; Tolazzi M; Chiappetta S; Nozza S; Lazzarin A; Tambussi G; Scarlatti G
    PLoS One; 2015; 10(10):e0140435. PubMed ID: 26474181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concerted effect of lymphopenia, viraemia and T-cell activation on Fas expression of peripheral B cells in HIV-1-infected patients.
    Rethi B; Sammicheli S; Amu S; Pensieroso S; Hejdeman B; Schepis D; Thang PH; Chiodi F
    AIDS; 2013 Jan; 27(2):155-62. PubMed ID: 23238551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spontaneous and anti-Fas-induced apoptosis in lymphocytes from HIV-infected patients undergoing highly active anti-retroviral therapy.
    Grelli S; Campagna S; Lichtner M; Ricci G; Vella S; Vullo V; Montella F; Di Fabio S; Favalli C; Mastino A; Macchi B
    AIDS; 2000 May; 14(8):939-49. PubMed ID: 10853975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV-1-infected children on HAART: immunologic features of three different levels of viral suppression.
    Zaccarelli-Filho CA; Ono E; Machado DM; Brunialti M; Succi RC; Salomão R; Kallás EG; de Moraes-Pinto MI
    Cytometry B Clin Cytom; 2007 Jan; 72(1):14-21. PubMed ID: 17041945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of peripheral HIV-1-specific memory B cells in patients untreated or receiving highly active antiretroviral therapy.
    Fondere JM; Huguet MF; Yssel H; Baillat V; Reynes J; van de Perre P; Vendrell JP
    AIDS; 2003 Nov; 17(16):2323-30. PubMed ID: 14571183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of hypergammaglobulinemia and impaired antigen-specific humoral immunity in HIV-1 infection.
    De Milito A; Nilsson A; Titanji K; Thorstensson R; Reizenstein E; Narita M; Grutzmeier S; Sönnerborg A; Chiodi F
    Blood; 2004 Mar; 103(6):2180-6. PubMed ID: 14604962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parallel decline of CD8+/CD38++ T cells and viraemia in response to quadruple highly active antiretroviral therapy in primary HIV infection.
    Tilling R; Kinloch S; Goh LE; Cooper D; Perrin L; Lampe F; Zaunders J; Hoen B; Tsoukas C; Andersson J; Janossy G;
    AIDS; 2002 Mar; 16(4):589-96. PubMed ID: 11873002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of antiretroviral regimes in HIV-1 patients in reducing immune activation.
    Jiménez A; Molero L; Jiménez A; Castañón S; Subirá D; De Górgolas M; Fedz-Guerrero M; García R
    Immunology; 2002 May; 106(1):80-6. PubMed ID: 11972635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Antiretroviral Therapy on the Memory and Activation Profiles of B Cells in HIV-Infected African Women.
    Tanko RF; Soares AP; Müller TL; Garrett NJ; Samsunder N; Abdool Karim Q; Abdool Karim SS; Riou C; Burgers WA
    J Immunol; 2017 Feb; 198(3):1220-1228. PubMed ID: 28039305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of control of T cell apoptosis under HAART. Influence of therapy regimen in vivo and in vitro.
    de Oliveira Pinto LM; Lecoeur H; Ledru E; Rapp C; Patey O; Gougeon ML
    AIDS; 2002 Feb; 16(3):329-39. PubMed ID: 11834943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Central memory CD4 T cells are associated with incomplete restoration of the CD4 T cell pool after treatment-induced long-term undetectable HIV viraemia.
    Rallón N; Sempere-Ortells JM; Soriano V; Benito JM
    J Antimicrob Chemother; 2013 Nov; 68(11):2616-25. PubMed ID: 23833186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence of immune reconstitution in antiretroviral drug-experienced patients with advanced HIV disease.
    Landay AL; Bettendorf D; Chan E; Spritzler J; Schmitz JL; Bucy RP; Gonzalez CJ; Schnizlein-Bick CT; Evans T; Squires KE; Phair JP
    AIDS Res Hum Retroviruses; 2002 Jan; 18(2):95-102. PubMed ID: 11839142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of combination chemotherapy and highly active antiretroviral therapy on immune parameters in HIV-1 associated lymphoma.
    Powles T; Imami N; Nelson M; Gazzard BG; Bower M
    AIDS; 2002 Mar; 16(4):531-6. PubMed ID: 11872995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasmacytoid dendritic cells mediate synergistic effects of HIV and lipopolysaccharide on CD27+ IgD- memory B cell apoptosis.
    Zhang L; Luo Z; Sieg SF; Funderburg NT; Yu X; Fu P; Wu H; Jiao Y; Gao Y; Greenspan NS; Harding CV; Kilby JM; Li Z; Lederman MM; Jiang W
    J Virol; 2014 Oct; 88(19):11430-41. PubMed ID: 25056888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Naive CD4+ T lymphocytes express high levels of Bcl-2 after highly active antiretroviral therapy for HIV infection.
    Airò P; Torti C; Uccelli MC; Malacarne F; Palvarini L; Carosi G; Castelli F
    AIDS Res Hum Retroviruses; 2000 Nov; 16(17):1805-7. PubMed ID: 11118066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and immunological benefits from highly active antiretroviral therapy in spite of limited viral load reduction in HIV type 1 infection.
    Hejdeman B; Lenkei R; Leandersson AC; Hultström AL; Wahren B; Sandström E; Bratt G
    AIDS Res Hum Retroviruses; 2001 Mar; 17(4):277-86. PubMed ID: 11242515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.